Ryzodeg 100IU/ml Flextouch Pen 3 ml used for the treatment of both type 1 and type 2 diabetes mellitus. It maintains blood sugar levels in adults and children. In Type 1 Diabetes Mellitus, the body does not produce enough insulin to regulate blood sugar levels. In type 2 diabetes mellitus, either the body stops producing enough insulin (a hormone that helps lower blood sugar levels) or there is resistance to the action of insulin. As a result, insulin is produced in large quantities, but it is unable to function properly on the body's organs.

Ryzodeg 100IU/ml Flextouch Pen 3 ml is a combination medicine that works by promoting the recovery of sugar in muscle and fat cells and suppressing sugar production in the liver. Together, Ryzodeg 100IU/ml Flextouch Pen 3 ml confirms rapid and stable sugar control.

Not everyone who is taking Ryzodeg 100IU/ml Flextouch Pen 3 ml will get these side effects. You may experience rash, injection site allergic reaction, weight gain, edema (tissue swelling or fluid overload), skin thickening at the injection site, low blood glucose levels, and itching. Most of these side effects of Ryzodeg 100IU/ml Flextouch Pen 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Ryzodeg 100IU/ml Flextouch Pen 3 ml should be taken before food or advised by your doctor. It should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks) only. Your doctor will explain how to inject the medicine by your own. However, if it is difficult to inject the medicine, ask a healthcare professional to administer it. Along with Ryzodeg 100IU/ml Flextouch Pen 3 ml, you should take a healthy diet, do regular exercise, and maintain weight as advised by your doctor. 

Inform your doctor if you are allergic to Ryzodeg 100IU/ml Flextouch Pen 3 ml. Do not take Ryzodeg 100IU/ml Flextouch Pen 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription or recreational drugs. Try not to stop receiving Ryzodeg 100IU/ml Flextouch Pen 3 ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Ryzodeg 100IU/ml Flextouch Pen 3 ml is a cold chain medicine, and so it must be stored in the refrigerator between 2-8 degrees Celsius, or else its efficiency might get lost. Do not store in the freezer or the fridge.

• Follow your doctor's instructions regarding the dosage and duration of treatment. • Ryzodeg 100IU/ml Flextouch Pen 3 ml should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks). • It should never be administered intravenously or in the vein. • If you are not well trained to self-administer it, ask a healthcare professional to administer it.

• Ryzodeg 100IU/ml Flextouch Pen 3 ml is an antidiabetic medicine primarily used for the treatment of both type 1 and type 2 diabetes mellitus.
• Ryzodeg 100IU/ml Flextouch Pen 3 ml works by ensuring rapid and consistent sugar control. It typically begins working after 60 minutes and is a long-acting insulin preparation (lasts for more than 24 hours). Together, they confirm rapid and stable sugar control by facilitating the reuptake of sugar in fat and muscle cells and suppressing the production of sugar in the liver.
• It prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells, thereby suppressing sugar production in the liver.
• Ryzodeg 100IU/ml Flextouch Pen 3 ml helps improve glycaemic control, which in turn decreases the risk of complications of diabetes, such as damage to the retina (retinopathy), damage to the kidneys (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcers, and others.
• Ryzodeg 100IU/ml Flextouch Pen 3 ml can also be safely prescribed to the diabetic mother during pregnancy and lactation.

Inform your doctor if you are allergic to Ryzodeg 100IU/ml Flextouch Pen 3 ml. Do not take Ryzodeg 100IU/ml Flextouch Pen 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription or recreational drugs. Try not to stop receiving Ryzodeg 100IU/ml Flextouch Pen 3 ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Ryzodeg 100IU/ml Flextouch Pen 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma, and even death.

Ryzodeg 100IU/ml Flextouch Pen 3 ml is for subcutaneous (under the skin) use only. If you are switching to a different insulin brand or using a different method of injection, it should be done under strict medical supervision. Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first symptoms of hyperglycemia (high blood sugar levels) may include excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite, and an acetone odour in the breath. You should closely monitor these symptoms.

It is advisable not to consume alcohol, as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Ryzodeg 100IU/ml Flextouch Pen 3 ml is a cold chain medicine, and therefore it must be stored in the refrigerator at a temperature between 2-8 degrees Celsius, or else its efficiency may be compromised. Do not store in the freezer or the fridge.

Keep the medicine out of reach of children. Please do not inject more than the recommended dose of medicine, as it can cause undesirable effects. It is always important to check the expiry date of the medicine. Discard the medicine if it reaches the expiry date. Ryzodeg 100IU/ml Flextouch Pen 3 ml should not be administered intravenously (into the vein).